Overview

Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This study is being done to examine the influence of Tiotropium (good or bad) on heart function at rest and during exercise in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborators:
Boehringer Ingelheim
Pfizer
Treatments:
Tiotropium Bromide